Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Biden Infrastructure Plan Offers Biopharma R&D Carrot, Tax Stick
Inversions Have Come Under Attack In Recent Years
Apr 05 2021
•
By
Alaric DeArment
The Biden administration's $2tn infrastructure plan includes massive investments in R&D and pandemic preparedness, and crackdowns on inversions and offshoring. • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Archive
More from Scrip